BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018; 10(11): 398-409 [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao Y, Chu Y, Hu Q, Song Q. Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer. J Res Med Sci 2021;26:24. [PMID: 34221053 DOI: 10.4103/jrms.JRMS_73_20] [Reference Citation Analysis]
2 Ge XY, Ge F, Wang Z, Wang YL, Lei LW, Liu QR, Sun XY, Jiang X. Analysis of risk factors of stage IV gastric cancer from the SEER database. Ann R Coll Surg Engl 2020;102:355-62. [PMID: 32326735 DOI: 10.1308/rcsann.2020.0031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Toyota S, Orita H, Fukuyama Y, Motoyoshi S, Kawanami S, Maeda S, Kuramitsu E, Ichimanda M, Nagamatsu S, Nagata S, Kai S, Korenaga D, Mori M. Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer. In Vivo 2020;34:583-5. [PMID: 32111756 DOI: 10.21873/invivo.11810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Li J, Xu Q, Wang W, Sun S. MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer. Biosci Rep 2019;39:BSR20190171. [PMID: 30886062 DOI: 10.1042/BSR20190171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
5 Choe HJ, Kim JW, Han SH, Lee JH, Ahn SH, Park DJ, Kim JW, Kim YJ, Lee HS, Kim JH, Kim HH, Lee KW. Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker. Cancers (Basel) 2019;12:E86. [PMID: 31905818 DOI: 10.3390/cancers12010086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Ushimaru Y, Nishikawa K, Yasuhara Y, Kawabata R, Makari Y, Fujita J, Kitagawa A, Ohara N, Miyake Y, Maeda S, Nakahira S, Nakata K, Miyamoto A. Successful laparoscopic conversion surgery for gastric cancer with para-aortic lymph node metastasis after third-line chemotherapy: a case report. Int Cancer Conf J 2021;:1-7. [PMID: 34660169 DOI: 10.1007/s13691-021-00516-9] [Reference Citation Analysis]
7 Shi T, Song X, Liu Q, Yang Y, Yu L, Liu B, Wei J. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study. Cancer Med 2019;8:6010-20. [PMID: 31448584 DOI: 10.1002/cam4.2521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Jung JO, Schulz ER, Nienhüser H, Sisic L, Müller BP, Diener MK, Büchler MW, Schmidt T. Characteristics and Prognostic Factors of Metachronous Second Primary Upper Gastrointestinal Cancer. J Surg Res 2021;258:254-64. [PMID: 33038603 DOI: 10.1016/j.jss.2020.08.075] [Reference Citation Analysis]
9 Beeharry MK, Zhang TQ, Liu WT, Gang ZZ. Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research. World J Surg Oncol 2020;18:51. [PMID: 32151257 DOI: 10.1186/s12957-020-01819-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Zhang F, Huang X, Song Y, Gao P, Zhou C, Guo Z, Shi J, Wu Z, Wang Z. Conversion Surgery for Stage IV Gastric Cancer. Front Oncol 2019;9:1158. [PMID: 31788445 DOI: 10.3389/fonc.2019.01158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Canbay E, Canbay Torun B, Cosarcan K, Altunal C, Gurbuz B, Bilgic C, Sezgin C, Kaban KK, Yilmaz S, Yazici Z. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. J Gastrointest Oncol 2021;12:S47-56. [PMID: 33968425 DOI: 10.21037/jgo-20-121] [Reference Citation Analysis]
12 Hayano K, Watanabe H, Ryuzaki T, Sawada N, Ohira G, Kano M, Uesato M, Matsubara H. Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy. Surg Case Rep 2020;6:219. [PMID: 32970254 DOI: 10.1186/s40792-020-00984-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Jin P, Ji X, Tian Y. Surgical management of oligometastatic disease in gastric cancer. Clin Res Hepatol Gastroenterol 2020;44:638-45. [PMID: 32147440 DOI: 10.1016/j.clinre.2020.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Guner A, Yildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol 2019;4:58. [PMID: 31559339 DOI: 10.21037/tgh.2019.08.03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Harada K, Zhao M, Shanbhag N, Baba H, Ajani JA. Palliative care for advanced gastric cancer. Expert Rev Anticancer Ther 2020;20:575-80. [PMID: 32543938 DOI: 10.1080/14737140.2020.1781620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Toyota S, Naito H, Motoyoshi S, Nakanishi R, Oki E, Orita H, Korenaga D. Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer. Surg Case Rep 2020;6:298. [PMID: 33237443 DOI: 10.1186/s40792-020-01040-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Shi K, Liu X, Du G, Cai X, Zhan Y. In vivo antitumour activity of Britanin against gastric cancer through nuclear factor-κB-mediated immune response. J Pharm Pharmacol 2020;72:607-18. [PMID: 31943207 DOI: 10.1111/jphp.13230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Matsumoto R, Arigami T, Matsushita D, Okubo K, Tanaka T, Yanagita S, Sasaki K, Noda M, Kita Y, Mori S, Kurahara H, Ohtsuka T. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. World J Surg Oncol 2020;18:179. [PMID: 32693806 DOI: 10.1186/s12957-020-01954-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]